These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20037206)

  • 21. The contribution of the DLG5 113A variant in early-onset inflammatory bowel disease.
    Russell RK; Drummond HE; Nimmo ER; Anderson N; Wilson DC; Gillett PM; McGrogan P; Hassan K; Weaver LT; Bisset WM; Mahdi G; Satsangi J
    J Pediatr; 2007 Mar; 150(3):268-73. PubMed ID: 17307543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transmission ratio distortion of DLG5 R30Q: evidence for prenatal selection?
    Henckaerts L; Vlietinck R; Derom C; Boonen S; Rutgeerts P; Vermeire S
    Inflamm Bowel Dis; 2010 Jun; 16(6):910-1. PubMed ID: 19774648
    [No Abstract]   [Full Text] [Related]  

  • 23. Identification of DLG5 and SLC22A5 gene polymorphisms in Malaysian patients with Crohn's disease.
    Chua KH; Lian LH; Kee BP; Thum CM; Lee WS; Hilmi I; Goh KL
    J Dig Dis; 2011 Dec; 12(6):459-66. PubMed ID: 22118696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association of DLG5 polymorphisms with inflammatory bowel disease: a meta-analysis of 25 studies.
    Dai YE; Guan R; Song YT
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2324-37. PubMed ID: 27338058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of polymorphisms of tumor necrosis factor-alpha and polymorphic xenobiotic metabolizing enzymes in inflammatory bowel disease: study from northern India.
    Mittal RD; Manchanda PK; Bid HK; Ghoshal UC
    J Gastroenterol Hepatol; 2007 Jun; 22(6):920-4. PubMed ID: 17565649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of IL23R, TNFRSF1A, and HLA-DRB1*0103 allele variants with inflammatory bowel disease phenotypes in the Finnish population.
    Lappalainen M; Halme L; Turunen U; Saavalainen P; Einarsdottir E; Färkkilä M; Kontula K; Paavola-Sakki P
    Inflamm Bowel Dis; 2008 Aug; 14(8):1118-24. PubMed ID: 18338763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial and sporadic inflammatory bowel disease: comparison of clinical features and serological markers in a genetically homogeneous population.
    Halme L; Turunen U; Heliö T; Paavola P; Walle T; Miettinen A; Järvinen H; Kontula K; Färkkilä M
    Scand J Gastroenterol; 2002 Jun; 37(6):692-8. PubMed ID: 12126248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the CC chemokine receptor 5 (CCR5) delta-32 polymorphism in inflammatory bowel disease.
    Rector A; Vermeire S; Thoelen I; Keyaerts E; Struyf F; Vlietinck R; Rutgeerts P; Van Ranst M
    Hum Genet; 2001 Mar; 108(3):190-3. PubMed ID: 11354628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C3435T polymorphism of the ABCB1/MDR1 gene encoding P-glycoprotein in patients with inflammatory bowel disease in a Polish population.
    Dudarewicz M; Barańska M; Rychlik-Sych M; Trzciński R; Dziki A; Skrętkowicz J
    Pharmacol Rep; 2012; 64(2):343-50. PubMed ID: 22661185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic polymorphism of ABCB1 gene (C3435T) in patients with inflammatory bowel diseases. Is there any gender dependency?
    Jaźwińska-Tarnawska E; Jęśkowiak I; Waszczuk E; Mulak A; Głowacka K; Hurkacz M; Paradowski L; Zaleska Z; Wiela-Hojeńska A
    Pharmacol Rep; 2015 Apr; 67(2):294-8. PubMed ID: 25712653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD.
    Vermeire S; Pierik M; Hlavaty T; Claessens G; van Schuerbeeck N; Joossens S; Ferrante M; Henckaerts L; Bueno de Mesquita M; Vlietinck R; Rutgeerts P
    Gastroenterology; 2005 Dec; 129(6):1845-53. PubMed ID: 16344053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin D receptor (VDR) TaqI polymorphism, vitamin D and bone mineral density in patients with inflammatory bowel diseases.
    Szymczak-Tomczak A; Krela-Kaźmierczak I; Kaczmarek-Ryś M; Hryhorowicz S; Stawczyk-Eder K; Szalata M; Skrzypczak-Zielińska M; Łykowska-Szuber L; Eder P; Michalak M; Dobrowolska A; Słomski R
    Adv Clin Exp Med; 2019 Jul; 28(7):955-960. PubMed ID: 30929318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-4 and Interleukin-10 Gene Polymorphisms in Patients with Inflammatory Bowel Disease.
    Ebrahimi Daryani N; Saghazadeh A; Moossavi S; Sadr M; Shahkarami S; Soltani S; Farhadi E; Rezaei N
    Immunol Invest; 2017 Oct; 46(7):714-729. PubMed ID: 28872970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease.
    Stokkers PC; van Aken BE; Basoski N; Reitsma PH; Tytgat GN; van Deventer SJ
    Gut; 1998 Jul; 43(1):33-9. PubMed ID: 9771403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction between seroreactivity to microbial antigens and genetics in Crohn's disease: is there a role for defensins?
    Lakatos PL; Altorjay I; Mándi Y; Lakatos L; Tumpek J; Kovacs A; Molnar T; Tulassay Z; Miheller P; Palatka K; Szamosi T; Fischer S; Papp J; ; Papp M
    Tissue Antigens; 2008 Jun; 71(6):552-9. PubMed ID: 18397186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease.
    Török HP; Glas J; Tonenchi L; Lohse P; Müller-Myhsok B; Limbersky O; Neugebauer C; Schnitzler F; Seiderer J; Tillack C; Brand S; Brünnler G; Jagiello P; Epplen JT; Griga T; Klein W; Schiemann U; Folwaczny M; Ochsenkühn T; Folwaczny C
    Gut; 2005 Oct; 54(10):1421-7. PubMed ID: 15955786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of DLG5 and inflammatory bowel disease across populations.
    Tenesa A; Noble C; Satsangi J; Dunlop M
    Eur J Hum Genet; 2006 Mar; 14(3):259-60; author reply 260-1. PubMed ID: 16391570
    [No Abstract]   [Full Text] [Related]  

  • 38. Analysis of keratin polypeptides 8 and 19 variants in inflammatory bowel disease.
    Tao GZ; Strnad P; Zhou Q; Kamal A; Zhang L; Madani ND; Kugathasan S; Brant SR; Cho JH; Omary MB; Duerr RH
    Clin Gastroenterol Hepatol; 2007 Jul; 5(7):857-64. PubMed ID: 17509943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of a positional candidate gene for inflammatory bowel disease: NRAMP2.
    Stokkers PC; Huibregtse K; Leegwater AC; Reitsma PH; Tytgat GN; van Deventer SJ
    Inflamm Bowel Dis; 2000 May; 6(2):92-8. PubMed ID: 10833067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CTLA-4 (+49A/G) and NOD2/CARD15 (N852S) polymorphisms with inflammatory bowel disease in Turkish patients.
    Budak Diler S; Yaraş S
    Cell Mol Biol (Noisy-le-grand); 2018 Aug; 64(11):97-101. PubMed ID: 30213296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.